Illustrating the functional heterogeneity of M-MDSCs to predict sepsis outcomes
Open Access
- 3 January 2026
- journal article
- Published by Elsevier in Journal of Advanced Research
- Vol. 88, 807-824
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82372324)
- National Key Research and Development Program of China (2022YFA1303500)
This publication has 79 references indexed in Scilit:
- Viral sepsis – pathophysiology and disease manifestationInfection, 2025
- Pulmonary fibrosis: pathogenesis and therapeutic strategiesMedcomm, 2024
- MDSCs in sepsis-induced immunosuppression and its potential therapeutic targetsCytokine & Growth Factor Reviews, 2022
- Dynamic changes in human single-cell transcriptional signatures during fatal sepsisJournal of Leukocyte Biology, 2021
- Deciphering myeloid-derived suppressor cells: isolation and markers in humans, mice and non-human primatesCancer Immunology, Immunotherapy, 2019
- MDSCs in infectious diseases: regulation, roles, and readjustmentCancer Immunology, Immunotherapy, 2018
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)JAMA, 2016
- Myeloid-derived suppressor cells control microbial sepsisIntensive Care Medicine, 2012
- Myeloid-derived suppressor cell heterogeneity and subset definitionCurrent Opinion in Immunology, 2010
- Efficient flow cytometric assay for platelet-leukocyte aggregates in whole blood using fluorescence signal triggeringCytometry, 1999